July 18, 2022
Merck today broke ground at its Sheboygan, Wisconsin site, for the company’s first lateral flow membrane production facility in the United States. New facility to manufacture the company’s Hi-Flow™ Plus lateral flow membrane used in rapid diagnostic test kit manufacturing, including Covid-19 Facility supported by € 121 million U.S. Government contract award Supports strategy to [...]
July 18, 2022
Global conference to focus on advancing the transformative impacts of genomic health SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that former President of the United States Barack Obama will participate in a moderated Q&A conversation at the inaugural Illumina Genomics Forum, the company's global event focused [...]
Biotium Introduces New Line of Antibodies for Exosome Detection
July 18, 2022
ExoBrite™ Antibody Conjugates are validated and optimized for bright and specific detection of exosome markers CD9, CD63, and CD81 for flow cytometry and western blotting. Fremont, CA – Life Science Newswire – Biotium, a leading supplier and inventor of fluorescent cellular probes for life science research, announces the release of new ExoBrite™ Antibody Conjugates. These [...]
Refractive Index Detector Kits for HPLC & uHPLC
July 18, 2022
Based on decades of experience in the chromatography field, TESTA Analytical Solutions e.K. has designed a Differential Refractive Index (DRI) detector kit adaptable to fulfil the specific demands of different HPLC system manufacturers. Despite their limited sensitivity, compared to other detectors such as UV or MS, the ability of DRI detectors to detect any analyte [...]
July 18, 2022
Unified data management platform provides unique small molecule drug discovery workflows to reduce increasing R&D costs Focused capabilities and templates provide a workspace supporting the entire make-test-decide innovation cycle, from hit discovery to lead optimization research Boston, MA – Dotmatics, a leader in R&D scientific software connecting science, data, and decision-making, today announced the release [...]
Pre-clinical screening technology increases cancer test numbers
July 15, 2022
A screening tool developed in research led at the University of Strathclyde, UK could increase the number of tests on a solid tumour sample by up to 50 times. The tool is designed for testing at scale the latest immunotherapies, such as Chimeric Antigen Receptor (CAR) T-cell therapy, which is effective against many haematological cancers but presents challenges when used to treat solid [...]
FUJIFILM Irvine Scientific Opens New Armstrong R&D Cell Culture Center of Excellence
July 14, 2022
Construction completed for expanded facility within California headquarters SANTA ANA, California, July 14, 2022: FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, has announced the completion of its Armstrong Cell Culture Center of Excellence. More than doubling the R&D [...]
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls
July 14, 2022
New synthetic controls add to growing portfolio of NGS applications for viral diseases SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today launched two human monkeypox virus synthetic DNA controls1. Positive controls provide quality control measures for the [...]
Microplate Optimised for Magnetic Bead Separations
July 14, 2022
Porvair Sciences has introduced a 96-well deep well microplate designed for labs using magnetic beads for nucleic acid purification, clean up and protein purifications. The 96-well magnetic bead separation plate has a reinforced base that can be routinely centrifuged at up to 6,000x g enabling faster magnetic bead separation protocols and improved sample quality. Manufactured in [...]
Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target
July 14, 2022
The Science Based Targets initiative has validated Illumina's targets to reach Net-Zero greenhouse gas emissions by 2050 SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today it is among the first group of companies worldwide to receive approval of its net-zero targets by the Science Based Targets initiative (SBTi). [...]
